Espoo, April 7th, 2025. Saide Genomics has signed commercial contracts with UK-based Nonacus and Finland-based Euformatics to supply consumables and
Espoo, March 27th, 2025. Euformatics has signed a commercial contract with India-based genomics company Bencos Healthcare Solution Pvt Ltd to
Introduction Next-Generation Sequencing (NGS) is transforming disease diagnosis and treatment by enabling fast and precise genetic analysis.
Introduction Clinical diagnostics are essential in identifying and managing medical conditions. Among its many tools, genetic testing stands
Genomics is transforming the landscape of modern medicine, paving the way for personalized treatments and improved approaches to disease
Since 2021, omnomicsNGS has held the CE-IVD mark under the In Vitro Diagnostics Directive (IVDD 98/79/EC). Euformatics Quality Manager Ashwini
Maneuvering through the world of clinical bioinformatics tools for next generation sequencing (NGS) is complicated on its own but also because of